Charles Schwab Investment Management Inc Gritstone Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 66,565 shares of GRTS stock, worth $1,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,565

Previous 66,565 -0.0%

Holding current value

$1,996

Previous $41,000 7.32%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.62 - $2.35 $124,396 - $471,504	-200,640 Reduced 75.09%	66,565 $41,000
Q4 2023 Feb 06, 2024	BUY	$1.28 - $2.85 $85,203 - $189,710	66,565 Added 33.18%	267,205 $545,000
Q3 2023 Nov 08, 2023	SELL	$1.19 - $2.26 $40,470 - $76,860	-34,009 Reduced 14.49%	200,640 $345,000
Q2 2023 Aug 09, 2023	BUY	$1.66 - $3.03 $333,062 - $607,939	200,640 Added 589.96%	234,649 $457,000
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $27,361 - $49,427	12,609 Added 58.92%	34,009 $117,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $166,284 - $407,725	-93,946 Reduced 81.45%	21,400 $52,000
Q1 2022 May 13, 2022	BUY	$4.03 - $12.19 $5,476 - $16,566	1,359 Added 1.19%	115,346 $476,000
Q4 2021 Feb 11, 2022	BUY	$8.76 - $13.71 $101,764 - $159,269	11,617 Added 11.35%	113,987 $1.47 Million
Q3 2021 Nov 16, 2021	SELL	$6.41 - $13.54 $493,255 - $1.04 Million	-76,951 Reduced 42.91%	102,370 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$8.13 - $10.2 $196,396 - $246,401	24,157 Added 15.57%	179,321 $1.64 Million
Q1 2021 May 17, 2021	BUY	$4.07 - $27.11 $55,567 - $370,132	13,653 Added 9.65%	155,164 $1.46 Million
Q4 2020 Feb 16, 2021	BUY	$2.57 - $4.22 $5,075 - $8,334	1,975 Added 1.42%	141,511 $558,000
Q3 2020 Nov 13, 2020	SELL	$2.63 - $8.09 $13,694 - $42,124	-5,207 Reduced 3.6%	139,536 $370,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $110,733 - $158,996	19,461 Added 15.53%	144,743 $962,000
Q1 2020 May 15, 2020	BUY	$5.47 - $11.3 $9,698 - $20,034	1,773 Added 1.44%	125,282 $730,000
Q4 2019 Feb 07, 2020	BUY	$7.07 - $11.61 $8,886 - $14,593	1,257 Added 1.03%	123,509 $1.11 Million
Q3 2019 Nov 08, 2019	BUY	$8.45 - $12.28 $12,379 - $17,990	1,465 Added 1.21%	122,252 $1.06 Million
Q2 2019 Aug 09, 2019	BUY	$9.2 - $15.7 $749,284 - $1.28 Million	81,444 Added 207.01%	120,787 $1.35 Million
Q1 2019 May 14, 2019	BUY	$9.97 - $18.96 $6,301 - $11,982	632 Added 1.63%	39,343 $524,000
Q4 2018 Feb 14, 2019	BUY	$11.61 - $31.1 $449,434 - $1.2 Million	38,711 New	38,711 $599,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Gritstone Bio, Inc. Transaction History